US9918968B2

Rapamycin analogs targeting proteasome function in the treatment of cancer

University of Texas System

Abstract

The invention claimed is: 1. A method of sensitizing a bortezomib-resistant cervical cancer cell to bortezomib in a subject comprising contacting said bortezomib-resistant cervical cancer cell with seco-rapamycin in an amount sufficient to inhibit said cancer cell. 2. The method of claim 1 ,

University: University of Texas System
Assignee: The Board Of Regents Of The University Of Texas System
Inventor: Maria E. GACZYNSKA
Priority date: January 03, 2013
Filing date: December 24, 2013
Grant date: March 20, 2018
Publication date: March 20, 2018
Language: en
PDF source: https://patentimages.storage.googleapis.com/de/d0/1e/31c7f992fbae06/US9918968.pdf
Metadata fetched: August 29, 2026 00:26